273 related articles for article (PubMed ID: 18241247)
1. Messenger RNA expression of monocyte chemoattractant protein-1 and interleukin-6 in stone-containing kidneys.
Boonla C; Hunapathed C; Bovornpadungkitti S; Poonpirome K; Tungsanga K; Sampatanukul P; Tosukhowong P
BJU Int; 2008 May; 101(9):1170-7. PubMed ID: 18241247
[TBL] [Abstract][Full Text] [Related]
2. Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases.
Szeto CC; Chan RW; Lai KB; Szeto CY; Chow KM; Li PK; Lai FM
Nephrol Dial Transplant; 2005 Jan; 20(1):105-13. PubMed ID: 15561743
[TBL] [Abstract][Full Text] [Related]
3. Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis.
Chan RW; Lai FM; Li EK; Tam LS; Wong TY; Szeto CY; Li PK; Szeto CC
Arthritis Rheum; 2004 Sep; 50(9):2882-90. PubMed ID: 15457456
[TBL] [Abstract][Full Text] [Related]
4. The effect of immunosuppressive therapy on the messenger RNA expression of target genes in the urinary sediment of patients with active lupus nephritis.
Chan RW; Lai FM; Li EK; Tam LS; Chow KM; Li PK; Szeto CC
Nephrol Dial Transplant; 2006 Jun; 21(6):1534-40. PubMed ID: 16449281
[TBL] [Abstract][Full Text] [Related]
5. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
[TBL] [Abstract][Full Text] [Related]
6. [Effects of induction of tubular epithelial-myofibroblast transition by monocyte chemoattractant protein-1 and mechanism thereof: an in vitro experiment].
Li HL; Zheng FL; Zhao B
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):400-5. PubMed ID: 18581895
[TBL] [Abstract][Full Text] [Related]
7. Monocyte chemoattractant protein 1 (MCP-1) gene expression in dilated cardiomyopathy.
Lehmann MH; Kühnert H; Müller S; Sigusch HH
Cytokine; 1998 Oct; 10(10):739-46. PubMed ID: 9811526
[TBL] [Abstract][Full Text] [Related]
8. [Effects of mechanical stress on expressions of monocyte chemoattractant protein-1 and interleukin-8 of cultured human retinal pigment epithelial cells].
Zhang XG; Hui YN; Han QH; Hou X; Chen LJ; Ma JX
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(32):2264-8. PubMed ID: 16321206
[TBL] [Abstract][Full Text] [Related]
9. [Expression of monocyte chemoattractant protein-1 and lupus nephritis].
Liu ZJ; Lin JY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):491-5. PubMed ID: 16178446
[TBL] [Abstract][Full Text] [Related]
10. Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study.
Chacón MR; Fernández-Real JM; Richart C; Megía A; Gómez JM; Miranda M; Caubet E; Pastor R; Masdevall C; Vilarrasa N; Ricard W; Vendrell J
Obesity (Silver Spring); 2007 Mar; 15(3):664-72. PubMed ID: 17372317
[TBL] [Abstract][Full Text] [Related]
11. [Effects of N-acetylcysteine on mRNA expression of monocyte chemotactic protein and macrophage inflammatory protein 2 in acute necrotizing pancreatitis: experiment with rats].
Xu CF; Wu AR; Shen YZ
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(10):711-5. PubMed ID: 18642776
[TBL] [Abstract][Full Text] [Related]
12. Monocyte chemoattractant protein-1 expression in renal tissue is associated with monocyte recruitment and tubulo-interstitial lesions in patients with lupus nephritis.
Dai C; Liu Z; Zhou H; Li L
Chin Med J (Engl); 2001 Aug; 114(8):864-8. PubMed ID: 11780369
[TBL] [Abstract][Full Text] [Related]
13. The expression of monocyte chemoattractant protein-1 and C-C chemokine receptor 2 in post-kidney transplant patients and the influence of simvastatin treatment.
Wang J; Zou H; Li Q; Wang Y; Xu Q
Clin Chim Acta; 2006 Nov; 373(1-2):44-8. PubMed ID: 16781696
[TBL] [Abstract][Full Text] [Related]
14. Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection.
Prodjosudjadi W; Daha MR; Gerritsma JS; Florijn KW; Barendregt JN; Bruijn JA; van der Woude FJ; van Es LA
Nephrol Dial Transplant; 1996 Jun; 11(6):1096-103. PubMed ID: 8671975
[TBL] [Abstract][Full Text] [Related]
15. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis.
Tam FW; Sanders JS; George A; Hammad T; Miller C; Dougan T; Cook HT; Kallenberg CG; Gaskin G; Levy JB; Pusey CD
Nephrol Dial Transplant; 2004 Nov; 19(11):2761-8. PubMed ID: 15353578
[TBL] [Abstract][Full Text] [Related]
16. Role of NAD(P)H oxidase in transforming growth factor-beta1-induced monocyte chemoattractant protein-1 and interleukin-6 expression in rat renal tubular epithelial cells.
Zhang H; Jiang Z; Chang J; Li X; Zhu H; Lan HY; Zhou SF; Yu X
Nephrology (Carlton); 2009 Apr; 14(3):302-10. PubMed ID: 19207862
[TBL] [Abstract][Full Text] [Related]
17. Semiquantitative analysis of intrahepatic CC-chemokine mRNas in chronic hepatitis C.
Nischalke HD; Nattermann J; Fischer HP; Sauerbruch T; Spengler U; Dumoulin FL
Mediators Inflamm; 2004 Dec; 13(5-6):357-9. PubMed ID: 15770052
[TBL] [Abstract][Full Text] [Related]
18. Macrophages contribute to the initiation of ischaemic acute renal failure in rats.
Jo SK; Sung SA; Cho WY; Go KJ; Kim HK
Nephrol Dial Transplant; 2006 May; 21(5):1231-9. PubMed ID: 16410269
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone protects diabetic rats against kidney disease through the suppression of renal moncyte chemoattractant protein-1 expression.
Zheng M; Ye S; Zhai Z; Chen Y; Li X; Yang G; Fan A; Wang Y
J Diabetes Complications; 2009; 23(2):124-9. PubMed ID: 18413206
[TBL] [Abstract][Full Text] [Related]
20. Urine chemokines as biomarkers of human systemic lupus erythematosus activity.
Rovin BH; Song H; Birmingham DJ; Hebert LA; Yu CY; Nagaraja HN
J Am Soc Nephrol; 2005 Feb; 16(2):467-73. PubMed ID: 15601744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
